Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00111579
Status:
COMPLETED
Last Update Posted:
2008-07-24
First Post:
2005-05-23
Brief Title:
Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine CAIV-T Compared With TIV
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Study Overview
Official Title:
A Prospective Randomized Open-Label Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine CAIV-T Compared With Trivalent Inactivated Vaccine TIV in Children 6 to 36 Months of Age
Status:
COMPLETED
Status Verified Date:
2008-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to describe the level of serum antibody conferred by CAIV-T and TIV against homotypic and heterotypic influenza virus strains
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None